Its March. Which means it is NephMadness.
In conjunction with NephMadness - Pain Region discussion, we discuss a recent JAMA Network Open study, reporting higher kidney risk in young men taking NSAIDs.
This week, we will discuss the CREDENCE trial, simply the most important nephrology trial in a generation.
This week we look at the treatment of depression in hemodialysis patients. It is cognitive behavorial therapy versus sertraline.